Director of Training, Global Medical Affairs
- Employment
- Full-time
- Company size
- Startup
Open to US only. Set where you work from to check your eligibility.
No BS summary
Director of Training for Global Medical Affairs to design and lead a comprehensive training strategy for specialized Medical and Commercial field teams. Requires building a training infrastructure for scientific rigor, operational fluency, and compliance in regulated advanced therapy treatment models. Must establish scalable onboarding, certification, and continuous development programs covering clinical science, CMC, and post-marketing obligations.
Kyverna Therapeutics is a patient-centered, clinical-stage biopharmaceutical company developing cell therapies for patients suffering from autoimmune diseases. Guided by our core values, Stay True to Why, Collaborate to Accelerate, Lead with Clarity, Boldly Innovative, and Own the Outcome, we are committed to transforming the future of treatment for autoimmune disease. Join us at the forefront of cell therapy innovation and help redefine what’s possible. Position Overview Kyverna is seeking a Director of Training, Global Medical Affairs, responsible for designing and leading a comprehensive, phase-appropriate training strategy to support highly specialized Medical and Commercial field teams responsible for commercializing miv-cel and other pipeline assets. The Director will build a training infrastructure that ensures Medical and Commercial teams are scientifically rigorous, operationally fluent, and compliant in highly regulated, chain-of-identity–dependent treatment models. The successful candidate will establish scalable onboarding, certification, and continuous capability development programs that integrate clinical science, CMC fundamentals, and post-marketing surveillance obligations unique to advanced therapies.
Department: Medical Affairs Reports to: Sr. Scientific Director, Medical Affairs Location: Remote Travel: Approximately 15%
What you'll do
- Designing and leading a comprehensive, phase-appropriate training strategy to support highly specialized Medical and Commercial field teams responsible for commercializing miv-cel and other pipeline assets.
- Build a training infrastructure that ensures Medical and Commercial teams are scientifically rigorous, operationally fluent, and compliant in highly regulated, chain-of-identity–dependent treatment models.
- Establish scalable onboarding, certification, and continuous capability development programs that integrate clinical science, CMC fundamentals, and post-marketing surveillance obligations unique to advanced therapies.
What they require
- Approximately 15% travel
Benefits
- bonus
- benefits
- participation in Company’s stock plan
Kyverna Therapeutics is a patient-centered, clinical-stage biopharmaceutical company developing cell therapies for patients suffering from autoimmune diseases.